AzTrials
AzTrials

Cystic FibrosisSAFETIM-needsNCT03298685

SAFETIM-needs : Exploring Adolescent's and Parent's Needs During Transition in French CF Centers

An observational study of Cystic Fibrosis and Adolescent Behavior, run by University Hospital, Grenoble at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

prospective multicentric study protocol in french CF center, exploring adolescent avec parents needs during transition from pediatric CF center to adult CF center Read more about this study

Who is it for?
Ages 17 to 23 yearsHealthy volunteers can take part
Conditions the study is for
Cystic Fibrosis, Adolescent Behavior
What is being tested?
semi structured interviews for all adolescents and their parent
How many people
50 participants
Where
4 sitesFrance
Study dates
12 Jun 2017to 31 Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 23 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: CF adolescent and their parents , for whom the transition to the adult center is scheduled within six months and witch have freely agreed to participate in the interviews their age will be between 17 and 23 years old. living followed in one of the 3 CF center

Who may be able to join

  • CF adolescent and their parents , for whom the transition to the adult center is scheduled within six months and witch have freely agreed to participate in the interviews

Who cannot join

  • none

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • University Hospital, Clermont-Ferrand

    Clermont-Ferrand, 63003

  • UniversityHospitalGrenoble

    Grenoble, 38043

  • Hôpital Femme Mère Enfant, HCL

    Lyon, 69322

  • South Hospital of Lyon, HCL

    Pierre-Bénite, 69495

Other trials in France

About this study

Official title: SAFETIM Besoins: Suivi Des Adolescents Des Familles et Des Equipes Pour Une Transition Idéale en Mucoviscidose Etude Des Besoins Adolescents et Parent Avant après Transition

prospective multicentric study protocol in french CF center, exploring adolescent avec parents needs during transition from pediatric CF center to adult CF center

Read the detailed description

Adolescent's and parent's needs will be studied, before the transition and their experiences of transition, in order to propose organizational national recommendations semi structured interview with adolescents and parents separately, before and after transition.

semi structured interviews will be conducted twice for each (adolescent and parents), the first in the 6 months before transition and the second in the 6 months after transition.

After their verbatims will be analyzed and the optimal organisation will be determined for the transition based according to their point of view.

At the end, the data from this study will be matched with data collected in a former study from care givers practices during transition in the french CF centers.

Being tested
semi structured interviews for all adolescents and their parent
Keywords
transition, care program, needs
Medical subject headings
Cystic Fibrosis, Adolescent Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • semi structured interviews for all adolescents and their parentOther

    Before and after transition, individual semi structured interviews will be recorded by one person in the same way in all CF center. And every interview will be transcribed by an other person

Study groups in NCT03298685
Study groupRoleWhat they receive
CF patient and parents cohort in 3 CF centerAll adolescents for whom the transition to the adult center is scheduled within six months and their parent will be interviewed before and after transition.
Receives: Other: semi structured interviews for all adolescents and their parent

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Identify CF adolescents and their parents needs before transition

    Qualitative analysis of interviews

    Measured: During their systematic appointment at the CF center, patients will have one individual interview during the year before transition. Interviews will be analyzed after all interviews will have been performed.

  2. Identify CF adolescents and their parents experience after transition

    Qualitative analysis of interviews

    Measured: During their systematic appointment at the CF center, patients will have one individual interview during the year after transition. Interviews will be analyzed after all interviews will have been performed.

Secondary outcomes (4)
  1. What do they need, to feel safe before transition

    Identify patients and parents needs

    Measured: During their systematic appointment at the CF center, patients and parents will have one individual interview during the year before transition. Interviews will be analyzed after all interviews will have been performed

  2. Do these needs of CFadolescent and their parents taken into account in the transition procedures

    Do the procedures take into account the needs of patients and parents

    Measured: During their systematic appointment at the CF center, patients and parents will have one individual interview during the year after transition. Interviews will be analyzed after all interviews will have been performed

  3. Which factors influence quality of transition other than TPE dimension.

    Satisfaction level of Patients and Family After Transition

    Measured: Interviews will be analyzed after an average of one year after the last interviews will have been performed, both outcome will be matched

  4. Do the resources implemented by the CRCM teams during the adolescent-adult transition matched with adolescents and parents needs and expectations

    Identifying key points of the patient's personalized transition, the timing and personalization of the health care course during the transition

    Measured: comparison between the results with health care practices one year after the last interview will be performed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2017
  2. Study start12 Jun 2017
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03298685
Sponsor's protocol ID
38RC17.005
Other IDs
2017-A00062-51
Acronym
SAFETIM-needs
Status last verified
Mar 2020
First submitted
1 Aug 2017
Last updated
30 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bregnballe V, Schiotz PO, Lomborg K. Parenting adolescents with cystic fibrosis: the adolescents' and young adults' perspectives. Patient Prefer Adherence. 2011;5:563-70. doi: 10.2147/PPA.S25870. Epub 2011 Nov 7.

    PubMed 22114471
  • Kreindler JL, Miller VA. Cystic fibrosis: addressing the transition from pediatric to adult-oriented health care. Patient Prefer Adherence. 2013 Dec 11;7:1221-6. doi: 10.2147/PPA.S37710.

    PubMed 24376344
  • Blum RW, Garell D, Hodgman CH, Jorissen TW, Okinow NA, Orr DP, Slap GB. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 1993 Nov;14(7):570-6. doi: 10.1016/1054-139x(93)90143-d. No abstract available.

    PubMed 8312295
  • Sawicki GS, Lukens-Bull K, Yin X, Demars N, Huang IC, Livingood W, Reiss J, Wood D. Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire. J Pediatr Psychol. 2011 Mar;36(2):160-71. doi: 10.1093/jpepsy/jsp128. Epub 2009 Dec 29.

    PubMed 20040605
  • Davis AM, Brown RF, Taylor JL, Epstein RA, McPheeters ML. Transition care for children with special health care needs. Pediatrics. 2014 Nov;134(5):900-8. doi: 10.1542/peds.2014-1909. Epub 2014 Oct 6.

    PubMed 25287460

Questions about this trial

What is this clinical trial studying?

An observational study of Cystic Fibrosis and Adolescent Behavior, run by University Hospital, Grenoble at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Identify CF adolescents and their parents needs before transition (time frame: During their systematic appointment at the CF center, patients will have one individual interview during the year before transition. Interviews will be analyzed after all interviews will have been performed.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03298685, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
SAFETIM-needs Clinical Trial NCT03298685 | AzTrials